PortfoliosLab logo

Achilles Therapeutics plc (ACHL)

Equity · Currency in USD · Last updated Nov 28, 2022

Company Info

ISINUS00449L1026
CUSIP00449L102
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$1.79
Year Range$1.59 - $5.57
EMA (50)$2.11
EMA (200)$2.95
Average Volume$55.62K
Market Capitalization$73.28M

ACHLShare Price Chart


Loading data...

ACHLPerformance

The chart shows the growth of $10,000 invested in Achilles Therapeutics plc in Apr 2021 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $1,148 for a total return of roughly -88.52%. All prices are adjusted for splits and dividends.


-40.00%-20.00%0.00%20.00%40.00%JuneJulyAugustSeptemberOctoberNovember
-24.02%
-2.57%
ACHL (Achilles Therapeutics plc)
Benchmark (^GSPC)

ACHLCompare to other instruments

Search for stocks, ETFs, and funds to compare with ACHL

ACHLReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-5.00%4.33%
6M-23.39%-0.78%
YTD-62.08%-15.53%
1Y-63.39%-14.36%
5Y-72.88%0.81%
10Y-72.88%0.81%

ACHLMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-24.15%-12.89%-11.18%-24.49%12.61%0.80%1.19%14.12%-22.34%-14.60%-1.55%
2021-6.04%-18.78%-22.49%-40.45%16.30%14.90%-21.18%-16.94%-1.76%

ACHLSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Achilles Therapeutics plc Sharpe ratio is -0.92. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.20-1.00-0.80-0.60-0.40-0.200.00JuneJulyAugustSeptemberOctoberNovember
-0.92
-0.60
ACHL (Achilles Therapeutics plc)
Benchmark (^GSPC)

ACHLDividend History


Achilles Therapeutics plc doesn't pay dividends

ACHLDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%December2022FebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovember
-89.36%
-16.06%
ACHL (Achilles Therapeutics plc)
Benchmark (^GSPC)

ACHLWorst Drawdowns

The table below shows the maximum drawdowns of the Achilles Therapeutics plc. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Achilles Therapeutics plc is 91.10%, recorded on Nov 9, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-91.1%Apr 7, 2021404Nov 9, 2022
-9.85%Apr 1, 20212Apr 5, 20211Apr 6, 20213

ACHLVolatility Chart

Current Achilles Therapeutics plc volatility is 69.68%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%100.00%120.00%JuneJulyAugustSeptemberOctoberNovember
69.68%
12.31%
ACHL (Achilles Therapeutics plc)
Benchmark (^GSPC)